Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Assets (2021 - 2025)

Historic Assets for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $111.3 million.

  • Biote's Assets rose 994.75% to $111.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.3 million, marking a year-over-year increase of 994.75%. This contributed to the annual value of $122.4 million for FY2024, which is 2120.16% down from last year.
  • As of Q3 2025, Biote's Assets stood at $111.3 million, which was up 994.75% from $104.8 million recorded in Q2 2025.
  • In the past 5 years, Biote's Assets ranged from a high of $319.0 million in Q1 2021 and a low of $54.3 million during Q4 2021
  • For the 5-year period, Biote's Assets averaged around $160.2 million, with its median value being $122.4 million (2024).
  • Data for Biote's Assets shows a peak YoY increase of 10549.42% (in 2022) and a maximum YoY decrease of 6556.69% (in 2022) over the last 5 years.
  • Over the past 5 years, Biote's Assets (Quarter) stood at $54.3 million in 2021, then skyrocketed by 105.49% to $111.6 million in 2022, then soared by 39.1% to $155.3 million in 2023, then fell by 21.2% to $122.4 million in 2024, then fell by 9.03% to $111.3 million in 2025.
  • Its Assets stands at $111.3 million for Q3 2025, versus $104.8 million for Q2 2025 and $123.4 million for Q1 2025.